DURHAM, N.C.--(BUSINESS WIRE)--Bioventus, a global leader in orthobiologic solutions, has entered into a definitive agreement to divest its next generation bone morphogenetic protein (BMP) development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback